Vistin Pharma ASA
VP4
Company Profile
Business description
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
Contact
Ostensjoveien 27
P.O. Box 6735 Etterstad
Oslo0661
NORT: +47 35984200
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
77
Stocks News & Analysis
stocks
Wide moat ASX share beats earnings guidance
Wide moat share continues to grow despite a challenging residential construction market.
stocks
Cheap with attractive yield: Fair Value lifted for retail REIT after earnings
Management expects both earnings and distributions to increase next year.
stocks
Cheap ASX share may have more room to run
Shares are cheap despite rebounding share price, yet risks remain.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,443.70 | 17.90 | 0.19% |
| CAC 40 | 8,714.94 | 11.09 | -0.13% |
| DAX 40 | 26,391.42 | 67.54 | 0.26% |
| Dow JONES (US) | 53,906.86 | 69.12 | -0.13% |
| FTSE 100 | 10,844.19 | 18.31 | -0.17% |
| HKSE | 25,652.82 | 284.67 | -1.10% |
| NASDAQ | 26,477.86 | 127.50 | -0.48% |
| Nikkei 225 | 66,970.22 | 1,363.51 | 2.08% |
| NZX 50 Index | 13,860.66 | 27.58 | -0.20% |
| S&P 500 | 7,736.71 | 16.40 | -0.21% |
| S&P/ASX 200 | 9,250.60 | 13.80 | 0.15% |
| SSE Composite Index | 3,934.09 | 32.50 | -0.82% |